Martin Shkreli Faces New Accusations Over High-Priced Drug

By BY CECILIA KANG from NYT Business
https://ift.tt/37y7t0L
A lawsuit by the Federal Trade Commission and New York’s attorney general says his company blocked generic rivals after sharply raising the cost of Daraprim.